SCHEDULE 13G/A: Brown Capital Management Discloses Continued Significant Stake in OrthoPediatrics Corp.

Brown Capital Management, LLC has filed an amended Schedule 13G, reporting a 7.77% beneficial ownership stake in OrthoPediatrics Corp.'s Class A common stock as of December 31, 2024.

Summary

• Brown Capital Management, LLC reported beneficial ownership of 1,882,405 shares of OrthoPediatrics Corp. Class A common stock.
• This represents 7.77% of the Class A common stock outstanding.
• The filing is an Amendment No. 7 to a previous Schedule 13G, indicating an update to an existing significant holding.
• Brown Capital Management, LLC holds sole voting power over 1,002,044 shares and sole dispositive power over all 1,882,405 shares.
• The shares are held for various investment advisory clients, and Granahan Investment Management LLC is also deemed a beneficial owner of these shares due to its discretionary power to make investment decisions and vote such shares.

Sentiment

Score: 5

Explanation: A Schedule 13G filing is a factual disclosure of beneficial ownership and does not inherently convey positive or negative sentiment regarding the issuer's performance or prospects. The maintenance of a significant institutional stake is generally neutral to slightly positive.

Positives

• The filing indicates that a significant institutional investor, Brown Capital Management, LLC, maintains a substantial 7.77% beneficial ownership stake in OrthoPediatrics Corp., which can be viewed as a sign of continued confidence in the company.

Negatives

• The Schedule 13G filing does not contain information regarding the operational or financial performance of OrthoPediatrics Corp. that would indicate negative aspects.

Risks

• NA

Future Outlook

NA

Management Comments

• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11.

Industry Context

NA

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake (7.77%) by Brown Capital Management, LLC, an investment adviser, provides transparency regarding the ownership structure and may signal continued institutional confidence in OrthoPediatrics Corp.

Key Dates

Keywords

OrthoPediatrics Corp., Brown Capital Management, Schedule 13G, Beneficial Ownership, Class A Common Stock, Institutional Investor, SEC Filing, Medical Devices, Pediatric Orthopedics